FREE CPD WEBINAR + Q&A
Oral Contraception: From Evidence to Practice
A practical, evidence-based guide for GPs on choosing and adjusting oral contraception across your patients' changing needs and life stages.
Wednesday 9 September 2026
7:30-9:00pm (VIC, NSW, QLD, ACT, TAS)
7:00-8:30pm (SA, NT)
5:30-7:00pm (WA)
References:
-
Therapeutic Guidelines. Choice of contraceptive method. Sexual and Reproductive Health. 2026.
-
RANZCOG C-Gyn 3 Contraception. 2024.
-
Black KI, et al. Best Pract Res Clin Obstet Gynaecol. 2025;98:102573.
-
Mu E, et al. Aust Prescr. 2022;45:75–79.
-
Women's Sexual and Reproductive Health Coalition. Increasing Access to Effective Contraception in Australia: A Consensus Statement. SPHERE; July 2022.
Event Countdown
Learning Outcomes
Upon completion of this education you will be able to:
1
Identify the range of clinical indications for oral contraceptives beyond contraception alone and apply this to patient-centred prescribing decisions.
2
Differentiate combined (COC) and progestogen-only (POP) oral contraceptives, applying pharmacology, Medical Eligibility Criteria (MEC, UK), risk profile, and PBS considerations to patient-centred prescribing decisions.
3
Manage common side effects of oral contraceptives confidently, including breakthrough bleeding, mood changes, and counselling around dispensing continuity.
About this education
Oral contraceptives are a commonly prescribed medicine in general practice, yet selecting the most appropriate formulation has become more complex as new preparations, PBS listings, and prescribing guidance evolve.¹⁻³ Choosing between combined oral contraceptives (COC) and progestogen-only pills (POP), understanding differences in safety profiles, and managing common adverse effects require a patient-centred, evidence-based approach.²⁻⁴
In this webinar, GP Dr Jenny Maxwell, obstetrician and gynaecologist Dr Gino Pecoraro, and GP Dr Natalia Rode present current evidence and clinical guidance on practical prescribing strategies for routine general practice. Through a longitudinal patient case, the panel discusses choosing the right oral contraceptive across different life stages, applying Medical Eligibility Criteria (MEC), navigating PBS considerations, managing breakthrough bleeding and other common adverse effects, and recognising when specialist referral is needed.²⁻⁵
The second half of the webinar is dedicated to live Q&A. The Q&A gives learners an opportunity to discuss challenging prescribing scenarios with an experienced multidisciplinary panel and gain practical insights that clinicians can apply in their consultations.
Steering committee
Continuing Professional Development (CPD) Details
This medical education activity has been approved for 1.5 Educational Activity hours, 5 Measuring Outcomes hours and 1 Reviewing Performance hour with:
Activity ID: 1670303
Activity ID: 2464
Activity ID: 42738
Automatic hours lodgement
RACGP and AMA/CPDHome members can now enjoy the convenience of rapid, automatic EA hours lodgement for this education. See your completed hours lodged within 24 hours.*
* Requires correct membership details.
Update yours now >
Please note that any additional reading or learning connected to this activity can be self recorded with your CPD body.
Praxhub is an accredited Major Provider under the RACGP CPD Program.
Praxhub is a Certified Learning Provider under the AMA's CPDHome CPD Program.
Praxhub acknowledges Arrotex and Bayer for its support of this education. The sponsors have provided no input into the content of this activity.